sulfinpyrazone has been researched along with arachidonic acid in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (84.62) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Gelman, JS; Mehta, J | 1 |
| Cerletti, C; de gaetano, G; del Maschio, A; Hatmi, M; Lefort, J; Vargaftig, BB | 1 |
| Kubik, MM; Richardson, SG | 1 |
| Cooper, DR; Kelliher, GJ; Kowey, PR | 1 |
| FitzGerald, GA; Pedersen, AK | 1 |
| Cerletti, C | 1 |
| Cerletti, C; De Gaetano, G; Del Maschio, A; Livio, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| Chignard, M; Lefort, J; Vargaftig, BB; Wal, F | 1 |
| Uotila, P | 1 |
| Berti, F; Folco, GC; Mantovani, M; Niada, R; Omini, C; Pescador, R; Porta, R; Prino, G; Viganò, T | 1 |
| Brian Houston, J; Hallifax, D; Knights, KM; Mackenzie, PI; Miners, JO; Nussio, MR; Rowland, A; Shapter, JG | 1 |
1 review(s) available for sulfinpyrazone and arachidonic acid
| Article | Year |
|---|---|
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Risk; Sulfinpyrazone; Thrombosis | 1985 |
1 trial(s) available for sulfinpyrazone and arachidonic acid
| Article | Year |
|---|---|
A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
Topics: Adult; Aged; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Count; Sulfinpyrazone | 1987 |
11 other study(ies) available for sulfinpyrazone and arachidonic acid
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Humans; Lung; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Sulfinpyrazone | 1987 |
Modulation of arachidonic acid metabolites and vulnerability to ventricular fibrillation during myocardial ischemia in the cat.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Cardiac Pacing, Artificial; Cats; Chromones; Coronary Disease; Female; Male; Naphthoquinones; ortho-Aminobenzoates; Pyrazoles; SRS-A; Sulfinpyrazone; Ventricular Fibrillation | 1988 |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1985 |
Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Humans; Indomethacin; Kinetics; Lipoxygenase; Models, Biological; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone | 1985 |
Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Kinetics; Malondialdehyde; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Topics: Adenosine Diphosphate; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Guinea Pigs; In Vitro Techniques; Lysophosphatidylcholines; Muscle Contraction; Platelet Activating Factor; Platelet Count; Sulfinpyrazone | 1982 |
Effect of sulfinpyrazone on the metabolism of arachidonic acid in isolated hamster lungs.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cricetinae; Hydrogen-Ion Concentration; In Vitro Techniques; Lung; Male; Mesocricetus; Sulfinpyrazone | 1982 |
PGI2-generation and antithrombotic activity of orally administered defibrotide.
Topics: Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Collagen; Cricetinae; DNA; Epoprostenol; Fibrinolytic Agents; Male; Mesocricetus; Muscle, Smooth, Vascular; Polydeoxyribonucleotides; Prostaglandins; Rabbits; Sulfinpyrazone; Thrombophlebitis | 1982 |
Characterization of the comparative drug binding to intra- (liver fatty acid binding protein) and extra- (human serum albumin) cellular proteins.
Topics: Anilino Naphthalenesulfonates; Arachidonic Acid; Base Sequence; Computer Simulation; Estradiol; Fatty Acid-Binding Proteins; Hepatocytes; Humans; Models, Theoretical; Molecular Sequence Data; Pharmaceutical Preparations; Pharmacokinetics; Serum Albumin; Sulfinpyrazone; Sulfonamides; Surface Plasmon Resonance; Torsemide; Ultrafiltration | 2015 |